Filing Details
Bionano Genomics, Inc. (NASDAQ:BNGO) filed a Form 8-K with the Securities and Exchange Commission on June 24, 2026, disclosing a material event.
8k filedNASDAQ:BNGO
Bionano Genomics, Inc. (BNGO) Reports Material Event to SEC
Filing Details Bionano Genomics, Inc. (NASDAQ:BNGO) filed a Form 8-K with the Securities and Exchange Commission on June 24, 2026, disclosing a material event. Market Context…
Market Context
Bionano Genomics, Inc.'s stock currently trades at $1.13 with a market capitalization of $5.5M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Bionano Genomics, Inc.'s stock.
All SEC filings for Bionano Genomics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BNGO Stock Page
Frequently Asked Questions
Where can I read BNGO's SEC filings?
Browse all filings on our BNGO SEC filings page.
What types of SEC filings does Bionano Genomics, Inc. file?
Public companies like Bionano Genomics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
